Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
The utility of magnetic resonance imaging for noninvasive evaluation of diabetic
nephropathy.
Authors
Brown RS, Sun MRM, Stillman IE, Russell TL, Rosas SE, Wei JL
Submitted By
Robert Brown on 8/19/2019
Status
Published
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Year
2019
Date Published
4/1/2019
Volume : Pages
Not Specified
:
Not Specified
PubMed Reference
31329940
Abstract
Noninvasive quantitative measurement of fibrosis in chronic kidney disease (CKD)
would be desirable diagnostically and therapeutically but standard radiologic
imaging is too variable for clinical usage. By applying a vibratory force,
tissue shear wave stiffness can be measured by magnetic resonance elastography
(MRE) that may correlate with progression of kidney fibrosis. Since decreased
kidney perfusion decreases tissue turgor and stiffness, we combined newly
available three-dimensional MRE shear stiffness measurements with MR arterial
spin labeling (ASL) kidney blood flow rates to evaluate fibrosis in diabetic
nephropathy., Thirty individuals with diabetes and Stage 0-5 CKD and 13 control
individuals without CKD underwent noncontrast MRE with concurrent ASL blood flow
measurements., MRE cortical shear stiffness at 90?Hz was decreased significantly
below controls in all CKD stages of diabetic nephropathy. Likewise, ASL blood
flow decreased progressively from 480?±?136?mL/min/100?g of cortical tissue in
controls to 302?±?95, 229?±?7 and 152?±?32?mL/min/100?g in Stages 3, 4 and 5
CKD, respectively. A magnetic resonance imaging (MRI) surrogate for the measured
glomerular filtration fraction [surrogate filtration fraction =?estimated
glomerular filtration rate (eGFR)/ASL] decreased progressively from 0.21?±?0.07
in controls to 0.16?±?0.04 in Stage 3 and 0.10?±?0.02 in Stage 4-5 CKD., In this
pilot study, MRI with ASL blood flow rates can noninvasively measure decreasing
kidney cortical tissue perfusion and, with eGFR, a decreasing surrogate
filtration fraction in worsening diabetic nephropathy that appears to correlate
with increasing fibrosis. Differing from the liver, MRE shear stiffness
surprisingly decreases with worsening CKD, likely related to decreased tissue
turgor from lower blood flow rates.
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!